Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems
The agreement, signed on March 4, 2024, lays the groundwork for further collaboration between Sharps and Roncadelle to develop and manufacture next-generation drug delivery products.
- The agreement, signed on March 4, 2024, lays the groundwork for further collaboration between Sharps and Roncadelle to develop and manufacture next-generation drug delivery products.
- “We believe that this is just the beginning of Sharps’ collaboration with Roncadelle.
- “This alliance underscores our unwavering commitment to innovation and excellence, reshaping standards within the global healthcare landscape.”
Sharps Technology specializes in the development and manufacturing of innovative drug delivery systems. - As part of the cooperative agreement, Sharps and Roncadelle intend to collaborate on the development of new drug delivery products.